Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Baylor College of Medicine Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for proven medical advice, trips or treatment using a real doctor. We are not doctors. Always confer with your physician about Baylor College of Medicine clinical studies. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Baylor College of Medicine Clinical research trials and Baylor College of Medicine healthcare trials take place in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectualness of new does drugs. The intent of the studies / projects is to answer certain human medical questions. Clinical trials are a popular way for mDs, government agencies, and private sector corporations like Baylor College of Medicine to detect remedies for all kinds of conditions. Baylor College of Medicine Clinical Trials and other clinical trials permit volunteers to get health treatment choices before they are available to the masses. Many times the participants recieve treatment for without cost, and sometimes they are compensated for their time. Sometimes there is a cost for a Baylor College of Medicine clinical trial. Participants frequently obtain the most effective healthcare available for their condition. Hazards are a reality, however, and could include additional or frequent doctor trips, medical risks (possibly life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with exacting guidelines to protect clinical trials subjects.

Home > "B" Clinical Trials Sponsors > Baylor College of Medicine Clinical Trials

Baylor College of Medicine Clinical Trials



A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients with Fanconi Anemia.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Anti-Human CD45 Monoclonal Antibodies in Patients with Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Autologous Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Bone marrow transplant from donor using less toxic conditioning for patient with high risk hemoglobinopathies
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Bone Marrow transplant from related donor for patients with high risk hemoglobinopathies
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients with Hematological Diseases
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

EBV-Specific CTLs Following CD45 Antibody to Patients with Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Gene marked cytotoxic T-cells for patients with relapsed Hodgkin's Lymphoma.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients who have had Donor Marrow Grafts.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Giving Gene Marked(Optional) Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Patients with Relapsed EBV-Positive Lymphoma,
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

High dose chemo/radiotherapy and hematopoietic stem cell transplant for patients with multiple sclerosis.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Intrathecal Gemcitabine in Treating Patients With Cancer and Neoplastic Meningitis
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Intrathecal Gemcitibine to Treat Neoplastic Meningitis
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Intrathecal Mafosfamide
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients with Inherited Metabolic Storage Diseases
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Stem Cell Transplant for Patients with Blood Malignancy Using Donors and Less Toxic Chemotherapy with CAMPATH 1H
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Stem Cell Transplant for Patients with Hematologic Malignancy Using Family Donors and Conditioning with Campath-1H
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Stem Cell Transplant to Treat Patients with Systemic Sclerosis
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Stem Cell Transplantation for Patients with Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning with CAMPATH 1H
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Study of Irinotecan in Children.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

The Effect of Oral Magnesium Pidolate on How Often Painful Crises Happens in Patients with Hemoglobin SC Disease
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Treating Severe Chronic Epstein-Barr Virus (EBV) Infection with EBV Specific Cytotoxic T Lymphocytes (CTLs)
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Treatment of B-CLL with Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Treatment of Chronic Lymphocytic B-Leukemia with IL-2 and CD-40 Autologous Tumor Cells
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Treatment of Resistant Langerhans Cell Histiocytosis with ENBREL
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma.
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Vaccine Therapy in Treating Patients With Relapsed Hodgkin's Lymphoma
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine

Valacyclovir in Immunocompromised Children
Condition: baylor_college_of_medicine_clinical_trials.html
Baylor College of Medicine



Baylor College of Medicine Clinical Trials
Modify your Search

Other "B" Clinical Trials Sponsors:

Baker Norton Pharmaceuticals
Baptist Hospital Of Miami
Barbara Ann Karmanos Cancer Institute
Barr Laboratories
Barrett Cancer Center
Bayer Corporation
Baylor College Of Medicine
Baylor University
Beckman Research Institute
Berlex Laboratories
Beth Israel Deaconess Medical Center
Biocodex
Biocryst Pharmaceuticals
Biocure Medical
Biogen Idec
Bioheart, Inc.
Biomarin Pharmaceutical
Biomeasure Inc, Ipsen Group
Biomedicines
Biomira Inc.
Bionumerik Pharmaceuticals, Inc.
Blood And Marrow Transplant Clinical Trials Network
Blumenthal Cancer Center At Carolinas Medical Center
Boehringer Ingelheim Pharmaceuticals
Boston Medical Center
Boston University School Of Medicine
Breast International Group
Brigham And Women's Hospital
Bristol-Myers Squibb
British Association Of Surgical Oncology: Breast Group
British Biotech Pharmaceuticals
British Columbia Cancer Agency
British National Lymphoma Investigation
British Thoracic Society
Burroughs Wellcome
Burzynski Research Institute


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103